Literature DB >> 15857005

Dissociation of clinical and laboratory diagnosis in hypothyroidism.

Sarita Bajaj1, G P Sharma, D Kumar, R Mehrotra.   

Abstract

AIMS OF THE STUDY: To assess the significance of clinical versus biochemical diagnosis of hypothyroidism using a clinical scoring index and optimize the therapeutic dose of levothyroxine in Indian patients.
METHODOLOGY: Three hundred and eighty eight cases of primary hypothyroidism (male:female ratio 1:5.8) were clinically classified as hypothyroid, euthyroid or inconclusive by Billewicz score. TSH estimation was repeated at 6-8 week intervals and appropriate adjustments in levothyroxine dosage made till the TSH was within the normal range.
RESULTS: Of 388 biochemically confirmed hypothyroid subjects less than one fourth (21.6%) could be classified as hypothyroid, almost one half were euthyroid (48.4%) and the remaining (29.9%) fell in the inconclusive category according to Billewiz score. Of 227 patients who returned for complete follow up there was a positive correlation of replacement dose with age and initial weight in females, but not in males. Baseline TSH values were not found to have a significant correlation with the initial dose. The mean replacement dose of levothyroxine (T4) in our subjects was 109.4 +/- 24.05 microg/d (range 1.25-3.84 microg/kg).
CONCLUSION: Clinical parameters alone fare poorly in establishing an unequivocal diagnosis of hypothyroidism. A biochemical confirmation is mandatory. The replacement done of T4 was found to be independent of the basal TSH level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857005

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  2 in total

1.  Study of Clinicobiochemical Spectrum of Hypothyroidism.

Authors:  S Sampath; P Singh; B L Somani; M M Arora; H S Batra; A K Harith; V Ambade
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Assessment of the Adequacy of Thyroid Hormone Replacement Therapy in Hypothyroidism.

Authors:  Matvey Brokhin; Sara Danzi; Irwin Klein
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-20       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.